EU
Emory University Portfolio holdings
AUM
$27.7M
1-Year Return
31.53%
This Quarter Return
+4.14%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$113M
AUM Growth
+$7.25M
(+6.8%)
Cap. Flow
+$7.7M
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
42.19%
Holding
57
New
16
Increased
8
Reduced
26
Closed
5
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.74M |
| 2 |
Esperion Therapeutics
ESPR
|
$2.16M |
| 3 |
Amicus Therapeutics
FOLD
|
$2.04M |
| 4 |
NXTM
NxStage Medical Inc.
NXTM
|
$1.8M |
| 5 |
Travere Therapeutics
TVTX
|
$1.77M |
Top Sells
| 1 |
Ardelyx
ARDX
|
$2.4M |
| 2 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$2.03M |
| 3 |
LPL Financial
LPLA
|
$1.59M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$1.54M |
| 5 |
Trinity Industries
TRN
|
$1.54M |
Sector Composition
| 1 | Healthcare | 43.85% |
| 2 | Financials | 32.05% |
| 3 | Technology | 5.46% |
| 4 | Energy | 4.39% |
| 5 | Consumer Discretionary | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
51
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.23M | 1.08% |
23,704
-10,948
| -32% | -$566K |
|
|
RARX
52
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.18M | 1.05% |
63,144
-40,462
| -39% | -$758K |
|
|
53
Ardelyx
ARDX
$1.58B
| – | – |
-189,477
| Closed | -$2.4M |
|
|
54
LPL Financial
LPLA
$28.8B
| – | – |
-39,989
| Closed | -$1.59M |
|
|
55
Trinity Industries
TRN
$2.31B
| – | – |
-80,402
| Closed | -$1.54M |
|
|
BLCM
56
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – |
-16,461
| Closed | -$2.03M |
|
|
FOMX
57
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – |
-203,519
| Closed | -$1.01M |
|